Shanghai MicroPort Endovascular MedTech Co., Ltd.

SHSE:688016 Stock Report

Market Cap: CN¥12.8b

Shanghai MicroPort Endovascular MedTech Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Qing Zhu

Chief executive officer

CN¥3.9m

Total compensation

CEO salary percentagen/a
CEO tenure6.3yrs
CEO ownershipn/a
Management average tenure3.7yrs
Board average tenure1.8yrs

Recent management updates

Recent updates

Shanghai MicroPort Endovascular MedTech's (SHSE:688016) Attractive Earnings Are Not All Good News For Shareholders

Nov 06
Shanghai MicroPort Endovascular MedTech's (SHSE:688016) Attractive Earnings Are Not All Good News For Shareholders

There's No Escaping Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Muted Earnings Despite A 31% Share Price Rise

Oct 01
There's No Escaping Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Muted Earnings Despite A 31% Share Price Rise

Earnings Miss: Shanghai MicroPort Endovascular MedTech Co., Ltd. Missed EPS By 16% And Analysts Are Revising Their Forecasts

Aug 29
Earnings Miss: Shanghai MicroPort Endovascular MedTech Co., Ltd. Missed EPS By 16% And Analysts Are Revising Their Forecasts

Shanghai MicroPort Endovascular MedTech (SHSE:688016) Will Want To Turn Around Its Return Trends

Aug 15
Shanghai MicroPort Endovascular MedTech (SHSE:688016) Will Want To Turn Around Its Return Trends

Investors Don't See Light At End Of Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Tunnel

Jun 29
Investors Don't See Light At End Of Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Tunnel

These 4 Measures Indicate That Shanghai MicroPort Endovascular MedTech (SHSE:688016) Is Using Debt Safely

Apr 29
These 4 Measures Indicate That Shanghai MicroPort Endovascular MedTech (SHSE:688016) Is Using Debt Safely

Shanghai MicroPort Endovascular MedTech's (SHSE:688016) Earnings Are Weaker Than They Seem

Apr 09
Shanghai MicroPort Endovascular MedTech's (SHSE:688016) Earnings Are Weaker Than They Seem

Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Business Is Trailing The Market But Its Shares Aren't

Mar 25
Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Business Is Trailing The Market But Its Shares Aren't

CEO

Qing Zhu (43 yo)

6.3yrs

Tenure

CN¥3,943,900

Compensation

Mr. Qing Zhu is GM & Director of Shanghai MicroPort Endovascular MedTech Co., Ltd. He was Deputy General Manager of Shanghai MicroPort Endovascular MedTech Co., Ltd.

Leadership Team

NamePositionTenureCompensationOwnership
Qing Zhu
GM & Directorno dataCN¥3.94mno data
Chun Fang Li
Accounting Supervisor & CFO3.1yrsCN¥1.21mno data
Genyong Qiu
Deputy GM & Secretary of the Board of Directors2.6yrsCN¥1.89mno data
Zhenyu Yuan
Deputy GM & Core Technical Personnel5.7yrsCN¥2.13mno data
Lantao Guo
Deputy GM & Core Technical Personnel4.3yrsCN¥1.79mno data
Ke Chen
Senior Directorno dataCN¥1.68mno data
Hongjie Lu
Core Technical Staffno dataCN¥488.00kno data
Liwen Wang
Core Technical Staffno dataCN¥687.10kno data

3.7yrs

Average Tenure

44yo

Average Age

Experienced Management: 688016's management team is considered experienced (3.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Qing Zhu
GM & Director6.3yrsCN¥3.94mno data
Jonathan H. Chen
Chairmanless than a yearno datano data
Linlin Cai
Employee Representative Supervisor6.3yrsno datano data
Xiaojie Ye
Independent Director2.7yrsno datano data
Min Liang
Chairman of the Supervisory Boardless than a yearno datano data
Chao Guo
Supervisorless than a yearno datano data

1.8yrs

Average Tenure

40.5yo

Average Age

Experienced Board: 688016's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.